Rahul Khosla

Max India and Max Ventures and Industries are yet to list, and we are expecting approvals by early to mid-May, says Rahul Khosla, Chairman of Max Life Insurance.

Max India: Change of guard; co splits into three

Explaining the rationale behind the split, Analjit Singh said at a press conference: "Over the years, we have been told that a lot of investors are interested in parts of what we do, but not necessarily the entire piece."

Max India shares gain 7% on court approval for demerger

"The Honourable High Court of Punjab and Haryana approved Max India‘s composite scheme of arrangement for demerger of company," says the diversified company in its filing.

Bupa to acquire addtnl 23% stake in Max Bupa for Rs 191 cr

The UK health care group was the first foreign insurer to announce its intent to increase its stake to 49 per cent in its Indian health insurance subsidiary after the government relaxed FDI participation rules for insurance companies.

Healthcare business EBITDA grew 60% in FY15: Max India

Max Life valuation currently stands at Ra 16,000-17,000 crore, while the embedded value stands at Rs 5,323 crore, Rahul Khosla, MD, Max India says

No regulatory hurdles if Bupa has to hike stake: Max India

In an interview to CNBC-TV18, Rahul Khosla, MD, Max India, speaking on the development, clarifies whether holding companies‘ foreign ownership would also be added into that category.

MD Rahul Khosla talks about his vision for Max India

CNBC-TV18's Senthil Chengalvarayan caught up with Khosla, on The Forbes India Show, to discuss his journey so far with Max and the road ahead.